⚠Due to planned maintenance you will experience short (<30 min) downtime between 08:00 - 08:30 CET.
Operational information
November 2023:
- Shipping donor’s blood samples for confirmatory typing is possible to all countries of the world with the exception of Syria, Cuba and North Korea. Shipping times depend on the specific country receiving the parcel with blood samples.
- Donor’s medical examination at the stage of confirmatory typing is carried out in Russia.
- Work-up and donor’s product collection *:
a) performed in Russia if courier can deliver the donor’s product from Russia to the transplant center;
b) performed outside Russia if courier is unable to deliver the donor’s product from Russia to the transplant center.
* In each case the decision is made jointly with the requesting registry taking into account the specific situation.
Contacts for requesting centers: e-mail: karelianbmd.donation@yahoo.com; karelian.bmd@onego.ru
tel: +7 905 299 91 8; fax: +7 8142 765 897
This data is publicly available. Parent page : ION-8256
Operational data for Karelian Registry of unrelated hematopoietic stem cell donors - ION-8256 | |
---|---|
Organisation Overview | |
The information has been reviewed in year : | 2023-2024 |
Issuing organisation Number (ION) | ION-8256 The Issuing Organisation Number of a organisation, this is globally unique number, as issued by the ICCBBA. |
Time zone | Europe/Moscow (GMT+03:00) The timezone in which this organisation operates. |
Business hours | 9 - 18 The daily hours in which this organisation operates. |
Work schedule | Monday - Friday The normal work week in which this organisation operates. |
Organisation closures | Jan, 1st For all organisation closures, please see the WMDA Calendar. |
Donor ID example | 82560000KAR00412827 ID to be expected on paperwork, samples, and products. |
Preliminary Search | |
Requires preliminary search request form | No If yes, form required can be found on the Documents Page. |
Extended Typing | |
Typing options available for request | HR, LR, ER HLA-A, B, C, DR, DQ, DP Please note special requirements listed |
Requires organisation specific typing request form | No If yes, form required can be found on the Documents Page. |
Number of days donor is reserved for a patient after a request | 90 days |
Verification Typing | |
Maximum blood volume allowed | 50 ml |
Requires organisation specific typing request form | No If yes, form required can be found on the Documents Page. |
IDM testing performed at verification | Yes |
Number of days donor is reserved for a patient after a request | 90 days |
Sibling Typing | |
Registry is willing to arrange sibling typings | Not applicable |
If yes, procedure to apply for sibling typings | |
Workup Request | |
Product dosage limit | 20 ml/kg (BM); 5 x 10^6 CD34+ cells/kg (PBSC) Number of donor cells allowed based on recipient weight. |
Requires patient to meet certain standards in order to proceed with collection | No Organisation may or may not allow donor collections for some patients. |
Patient physician must report the following in order to proceed with collection | Patient physician needs to provide the report of patient status and treatment plan. For export of the blood samples for verification typing, you will have to fill in a special agreement, which you can find in the membership documents session. Blood samples can be shipped on Monday, Tuesday and Wednesday. Must provide additional information to organisation. |
Requires organisation specific work up forms | No If yes, form(s) required can be found on the Documents Page. |
Workup IDM completed 30 days prior to collection | Yes Donor IDM results must be performed within 30 days of collection date to be valid and allow the collection to proceed. |
Medical Health Questionnaire example available | Yes If yes, the example can be found on the Documents Page. |
Post-Transplant | |
Subsequent donation policy | Possible |
Anonymous contact allowed | Yes. As far as possible |
Direct contact allowed | Yes. 3 years after transplant |
Gift exchange allowed | Yes, but gift must not be of substantial or monetary value |
Cord blood contact allowed | No |
IDM
IDM | Tested | Method | Days between test and sampling/workup |
---|---|---|---|
ALT/ASTALT/AST ratio, De-Ritis-Quotient | Yes | 7-10 | |
ChagasChagas, T. cruzi | On request | ||
CMV IgGCytomegalovirus (CMV) Antibody testing IgG | Yes | 7-10 | |
CMV IgMCytomegalovirus (CMV) Antibody testing IgM | Yes | 7-10 | |
CMV TotalCytomegalovirus Total | Yes | 7-10 | |
EBV IgGEpstein-Barr Virus Antibody testing IgG | Yes | 7-10 | |
EBV IgMEpstein-Barr Virus Antibody testing IgM | Yes | 7-10 | |
HAV (NAT)Anti-hepatitis A virus nucleic acid testing | Yes | 7-10 | |
HBV (NAT)Hepatitis B nucleic acid testing | Yes | 7-10 | |
HBc AbHepatitis B core antibody testing | Yes | 7-10 | |
HBs AgHepatitis B Surface antigen testing | Yes | 7-10 | |
HCV (NAT)Hepatitis C nucleic acid testing | Yes | 7-10 | |
HCV AbHepatitis C antibody testing | Yes | 7-10 | |
HEV (NAT)Hepatitis E Virus nucleic acid testing | On request | 7-10 | |
HIV (NAT)Human Immunodeficiency Virus nucleic acid testing | Yes | 7-10 | |
HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing | Yes | 7-10 | |
HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing | Yes | 7-10 | |
HIV p24Human Immunodeficiency Virus p24 antigen testing | Yes | 7-10 | |
HTLV-IHuman T-Lymphotropic Virus type I testing | On request | 7-10 | |
HTLV-IIHuman T-Lymphotropic Virus type II testing | On request | 7-10 | |
MalariaMalaria | On request | 7-10 | |
HSVHerpes Simplex Virus | Yes | 7-10 | |
STSSerological tests for syphilis | Yes | 7-10 | |
STS FTA-ABSSerological test for syphilis | On request | 7-10 | |
ToxoplasmosisToxoplasmosis | Yes | 7-10 | |
VZVVaricella Zoster Virus | On request | 7-10 | |
WNV-NATWest Nile Virus nucleic acid testing | On request | 7-10 | |
Other tests performed | On request | 7-10 |
Regulatory information
The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
General | |
---|---|
The information has been reviewed in year : | 2023 |
Organisation name: | Karelian Registry of Hematopoietic Stem Cells |
Organisation ION: | ION-8256 |
Country: | Russian Federation |
Year the registry started operations: | 2001 |
Products | comment | |
---|---|---|
Do you provide HPC, Marrow? | yes | |
Do you provide HPC, Apheresis? | yes | |
Do you provide HPC, Cord Blood? | no | |
Do you provide MNC, Apheresis? | yes | |
Do you provide NC, Whole Blood? | yes |
Product quantity | ||
---|---|---|
Data valid for year | 2022 | |
Number of products | National | International |
HPC, Marrow products: | 0 | 0 |
HPC, Apheresis: | 3 | 1 |
HPC, Cord: | 0 | 0 |
License | |
---|---|
Organisation is licensed/accredited by the Health Authority: | yes |
Comment: | |
Name of Health Authority: | The Ministry of health of the Republic of Karelia |
Date of last inspection: | 2016/03/22 |
Link to website of Health Authority: | http://mzsocial-rk.ru/ |
Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ? | |
The registry is accredited by any other organisation: | |
If yes, by which organisation? |
Donor policy | |
---|---|
All donors are unpaid volunteers: | yes |
All donors are informed about donation process and associated risks: | yes |
Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: | yes |
The registry has systems in place to protect and control access to donor/patient records: | yes |
The registry maintains donor anonymity: | yes |
The registry has detailed donor evaluation and exclusion criteria in place: | yes |
The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines: | yes |
Regulatory information section 2
Relevant documents will be uploaded by the organisation to the documents page.Testing | |
---|---|
The physical and medical exam at donor workup is performed by a medical doctor: | yes |
All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: | yes |
HLA typing for patient specific request is performed in an appropriately accredited laboratory: | yes |
Sterility testing is performed on the adult donor product: | yes |
Sterility testing is performed on the cord blood product: | |
Screening questionnaire to exclude communicable disease: | yes |
Screening questionnaire to exclude donors with 'high risk' lifestyles: | yes |
Donor reliability identified by a medical doctor: | yes |
Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC : | yes |
Customs regulations | |
---|---|
Are there any customs regulations to follow, or customs paperwork required, to import cell products into the organisation country? | Request for PBSC/BM, license for the PBSC/BM collection, donor consent, agreement between the registry and the transplant center, proforma invoice |
Are there any customs regulations to follow, or customs paperwork required, to export cell products from the organisation country? | Request for PBSC/BM, license for the PBSC/BM collection, donor consent, agreement between the registry and the transplant center, proforma invoice |
Are there any import regulations to follow, or paperwork required, to import cell products into the organisation country? | Request for PBSC/BM, license for the PBSC/BM collection, donor consent, agreement between the registry and the transplant center |
Are there any export regulations to follow, or paperwork required, to export cell products from the organisation country? | Request for PBSC/BM, license for the PBSC/BM collection, donor consent, agreement between the registry and the transplant center |
Reporting of Serious Adverse Events | |
---|---|
Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in: | |
- Mandatory National Reporting Scheme | no |
- Voluntary National Reporting Scheme | yes |
- WMDA SEAR/SPEAR Reporting Scheme | yes |
The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product: | yes |
Quality management | |
---|---|
The registry does maintain Standard Operating Procedures for your work: | yes |
Please indicate if your organisation/country has any specific requirements that should be communicated in advance to the requesting entity (e.g., financial sanctions, specific regulatory forms, etc.) : | |
Donor records relating to the medical exam and cell product collection process are the following number(s) of year(s) retained: | 30 years |